Cerca
Treatment Settings
Various treatment formats, either in a live-in facility or through regular visits to a clinic, are designed for ongoing support, to help maintain recovery, and to prevent relapse.
Comparative Effectiveness of Pharmacotherapies for the Risk of Attempted or Completed Suicide Among Persons With Borderline Personality Disorder
Abstract
Importance Suicidal behavior is a significant clinical concern in individuals with borderline personality disorder (BPD), but the effectiveness of pharmacotherapy on reducing suicide risk has remained unknown.
Objective To...
Continuum of Care in Recovery
Resoconti di donne identificate come bevitrici ad "alto rischio" durante la gravidanza
Bere alcolici durante la gravidanza è associato ai disturbi dello spettro alcolico fetale (FASD) e le donne che bevono a livelli più elevati hanno maggiori probabilità di avere un bambino con FASD.
Gli sforzi per comprendere e rispondere...
Webinar sulla prevenzione delle dipendenze per i giovani
L'International Society of Substance Use Professionals (ISSUP) Indonesia e l'Indonesia International Training and Treatment Centre (ITTC) hanno ospitato insieme il secondo webinar su "Prevenzione delle dipendenze per i giovani" domenica 21...
Formazione online INEP Plus in Indonesia
ISSUP Indonesia ha organizzato il corso online Introduction to Evidence-Based Prevention (INEP) come formazione a livello nazionale in Indonesia con 17 partecipanti. La formazione, condotta dalla Dott.ssa Kristiana Siste, SpKJ, e dalla...
Treatment for drug and alcohol misuse should involve families and communities
Alcohol and other drug treatment are generally only provided for individuals, often away from their families. Treatment aims to improve well-being and reduce the harms of substance use and families and communities can play a significant...
FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder
For Immediate Release: May 23, 2023
Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD)...
La FDA aprueba una nueva opción de tratamiento con buprenorfina para el trastorno por consumo de opioides
Para publicación inmediata: 24 de mayo del 2023
Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) aprobó la inyección subcutánea (para uso por debajo de la piel) de Brixadi...
Covering Substance Use and Addiction Responsibly
Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention
Abstract
Substance use disorders (SUDs) are highly prevalent and impact individuals' health, well-being, and social functioning. Long-lasting changes in brain networks involved in reward, executive function, stress reactivity, mood, and...
Assessment of Medical Cannabis and Health-Related Quality of Life
Abstract
Importance The use of cannabis as a medicine is becoming increasingly prevalent. Given the diverse range of conditions being treated with medical cannabis, as well as the vast array of products and dose forms available, clinical...
SMART recovery for youth: un piccolo studio qualitativo esplorativo che esamina il potenziale di un programma di cambiamento comportamentale di mutuo soccorso e sostegno tra pari per i giovani
Astratto
Sfondo
SMART (Self-Management and Recovery Training) Recovery è un programma di mutuo soccorso informato dalla terapia cognitivo-comportamentale e dal colloquio motivazionale che fornisce supporto per una serie di comportamenti...
Strategies to Address Cocaine and Methamphetamine
Presented by Richard Rawson, PhD, Emeritus Professor in the Department of Psychiatry and Biobehavioral Science, UCLA School of Medicine and a Research Professor at the University of Vermont, this presentation provided an overview of the...
Character Strengths and Recovery from Addiction
UNODC supported delegations from four Central Asian countries in a high-level study tour to the United Kingdom
The UNODC Regional Office for Central Asia (ROCA) together with the UNODC Prevention, Treatment and Rehabilitation Section (PTRS) organized a study tour for high-level representatives, including senior officials, policymakers and substance...
National Drug Council equipping professionals with capacity to effectively treat substance use disorders in adolescents
Buprenorphine versus methadone for the treatment of opioid dependence
Summary
Background
Opioid dependence is associated with substantial health and social burdens, and opioid agonist treatment (OAT) is highly effective in improving multiple outcomes for people who receive this treatment. Methadone and...
Economic Evaluations of Pharmacologic Treatment for Opioid Use Disorder: A Systematic Literature Review
Abstract
Objective
The crisis of opioid use puts a strain on resources in the United States and worldwide. There are 3 US Food and Drug Administration–approved medications for treatment of opioid use disorder: methadone, buprenorphine...
Focal mu-opioid receptor activation promotes neuroinflammation and microglial activation in the mesocorticolimbic system: Alterations induced by inflammatory pain
Abstract
Microglia participates in the modulation of pain signaling. The activation of microglia is suggested to play an important role in affective disorders that are related to a dysfunction of the mesocorticolimbic system (MCLS) and are...
Implementation and workflow strategies for integrating digital therapeutics for alcohol use disorders into primary care: a qualitative study
Abstract
Background
Alcohol use disorders (AUD) are prevalent and often go untreated. Patients are commonly screened for AUD in primary care, but existing treatment programs are failing to meet demand. Digital therapeutics include novel...
Share the Knowledge: ISSUP members can post in the Knowledge Share – Sign in or become a member